184 related articles for article (PubMed ID: 10492380)
41. Folate receptor targeted imaging using poly (ethylene glycol)-folate: in vitro and in vivo studies.
Kim SL; Jeong HJ; Kim EM; Lee CM; Kwon TH; Sohn MH
J Korean Med Sci; 2007 Jun; 22(3):405-11. PubMed ID: 17596645
[TBL] [Abstract][Full Text] [Related]
42. A new 18F-labeled folic acid derivative with improved properties for the PET imaging of folate receptor-positive tumors.
Ross TL; Honer M; Müller C; Groehn V; Schibli R; Ametamey SM
J Nucl Med; 2010 Nov; 51(11):1756-62. PubMed ID: 20956469
[TBL] [Abstract][Full Text] [Related]
43. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
44. A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for α- and β- radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted folate derivative.
Müller C; Zhernosekov K; Köster U; Johnston K; Dorrer H; Hohn A; van der Walt NT; Türler A; Schibli R
J Nucl Med; 2012 Dec; 53(12):1951-9. PubMed ID: 23139086
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of a novel radiofolate in tumour-bearing mice: promising prospects for folate-based radionuclide therapy.
Müller C; Mindt TL; de Jong M; Schibli R
Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):938-46. PubMed ID: 19183997
[TBL] [Abstract][Full Text] [Related]
46. [Feasibility of apoptosis-imaging agent 99mTc-HYNIC-annexin V in early assessment of chemotherapeutic effect on tumor models].
Lan XL; Zhang YX; He Y; Sun X; An R; Gao ZR; Cao GX
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):737-40. PubMed ID: 19173800
[TBL] [Abstract][Full Text] [Related]
47. Arthritis imaging using a near-infrared fluorescence folate-targeted probe.
Chen WT; Mahmood U; Weissleder R; Tung CH
Arthritis Res Ther; 2005; 7(2):R310-7. PubMed ID: 15743478
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells.
Dixit V; Van den Bossche J; Sherman DM; Thompson DH; Andres RP
Bioconjug Chem; 2006; 17(3):603-9. PubMed ID: 16704197
[TBL] [Abstract][Full Text] [Related]
49. Imaging tumor folate receptors using 111In-DTPA-methotrexate.
Ilgan S; Yang DJ; Higuchi T; Zareneyrizi F; Kim EE; Podoloff DA
Cancer Biother Radiopharm; 1998 Jun; 13(3):177-84. PubMed ID: 10850353
[TBL] [Abstract][Full Text] [Related]
50. Receptor-mediated targeting of 67Ga-deferoxamine-folate to folate-receptor-positive human KB tumor xenografts.
Mathias CJ; Wang S; Low PS; Waters DJ; Green MA
Nucl Med Biol; 1999 Jan; 26(1):23-5. PubMed ID: 10096497
[TBL] [Abstract][Full Text] [Related]
51. Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis.
Turk MJ; Breur GJ; Widmer WR; Paulos CM; Xu LC; Grote LA; Low PS
Arthritis Rheum; 2002 Jul; 46(7):1947-55. PubMed ID: 12124880
[TBL] [Abstract][Full Text] [Related]
52. BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors.
Gibbs DD; Theti DS; Wood N; Green M; Raynaud F; Valenti M; Forster MD; Mitchell F; Bavetsias V; Henderson E; Jackman AL
Cancer Res; 2005 Dec; 65(24):11721-8. PubMed ID: 16357184
[TBL] [Abstract][Full Text] [Related]
53. 99mTc-labeling of HYNIC-conjugated cyclic RGDfK dimer and tetramer using EDDA as coligand.
Wang J; Kim YS; Liu S
Bioconjug Chem; 2008 Mar; 19(3):634-42. PubMed ID: 18281926
[TBL] [Abstract][Full Text] [Related]
54. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.
Leamon CP; Cooper SR; Hardee GE
Bioconjug Chem; 2003; 14(4):738-47. PubMed ID: 12862426
[TBL] [Abstract][Full Text] [Related]
55. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
Edwards DS; Liu S; Barrett JA; Harris AR; Looby RJ; Ziegler MC; Heminway SJ; Carroll TR
Bioconjug Chem; 1997; 8(2):146-54. PubMed ID: 9095354
[TBL] [Abstract][Full Text] [Related]
56. Biodistribution of a 153 Gd-folate dendrimer, generation = 4, in mice with folate-receptor positive and negative ovarian tumor xenografts.
Konda SD; Wang S; Brechbiel M; Wiener EC
Invest Radiol; 2002 Apr; 37(4):199-204. PubMed ID: 11923642
[TBL] [Abstract][Full Text] [Related]
57. Impact of high and low folate diets on tissue folate receptor levels and antitumor responses toward folate-drug conjugates.
Leamon CP; Reddy JA; Dorton R; Bloomfield A; Emsweller K; Parker N; Westrick E
J Pharmacol Exp Ther; 2008 Dec; 327(3):918-25. PubMed ID: 18791065
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical.
Leamon CP; Parker MA; Vlahov IR; Xu LC; Reddy JA; Vetzel M; Douglas N
Bioconjug Chem; 2002; 13(6):1200-10. PubMed ID: 12440854
[TBL] [Abstract][Full Text] [Related]
59. Asialoglycoprotein-receptor-targeted hepatocyte imaging using 99mTc galactosylated chitosan.
Kim EM; Jeong HJ; Kim SL; Sohn MH; Nah JW; Bom HS; Park IK; Cho CS
Nucl Med Biol; 2006 May; 33(4):529-34. PubMed ID: 16720245
[TBL] [Abstract][Full Text] [Related]
60. [Folate receptor and its application in the selective receptor-mediated targeting therapy of tumor cells--review].
Gao XN; Tang SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):911-4. PubMed ID: 16277870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
